Anthracycline associated cardiotoxicity in survivors of childhood cancer
- 4 October 2007
- Vol. 94 (4), 525-533
- https://doi.org/10.1136/hrt.2007.136093
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late EffectsJournal of Clinical Oncology, 2007
- Prevention of anthracycline-induced cardiotoxicity in children: The evidenceEuropean Journal of Cancer, 2007
- Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and managementExpert Opinion on Pharmacotherapy, 2007
- Long-term effects of treatments for childhood cancersCurrent Opinion in Pediatrics, 2007
- Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategiesBritish Journal of Haematology, 2005
- Cardiac Changes Associated With Growth Hormone Therapy Among Children Treated With AnthracyclinesPEDIATRICS, 2005
- Cardioprotective interventions for cancer patients receiving anthracyclinesPublished by Wiley ,2005
- Cardiovascular Trials in Long-Term Survivors of Childhood CancerJournal of Clinical Oncology, 2004
- Different anthracycline derivates for reducing cardiotoxicity in cancer patientsPublished by Wiley ,2004
- Long-Term Enalapril Therapy for Left Ventricular Dysfunction in Doxorubicin-Treated Survivors of Childhood CancerJournal of Clinical Oncology, 2002